-3...
thanks for your recent updates. very appreciated, especially in light of the company's own seeming reluctance to communicate with their shareholders. they really do themselves a disservice in that regard. i read the stockhouse board but am not a contributor there as there are some very informed posters there as you note. another lesser informed voice is not really needed.
i have spoken with the company not long ago with mixed success. i asked them to update their "investor information" page on their site with access to current financials, which was showing "latest info" from march 2019. That was done...now showing access to 2020 financials but the march 2019 date is still showing for stock/warrant/option count. just sloppy. i also requested a shareholder update/overview, even if there was not much of import to say. i said it's important to hear from company to help shareholder confidence and for "team-building" at a time when many are nervous and/or losing patience. we'll see about that one, but today's news that agm was postponed due to covid suggests that ain't happening soon. so lame, especially in the era of zoom calls. no one is looking for "tall tales"at this point. just a sense how company is approaching the coming months...and that it is still on the job. perhaps an update on new indication(s). just a reasonable corporate "proof of life". Not so much to ask...
will contact them again before too long... for now, not holding my breath. there is a possibility, i suppose, that prelim results for first 10-ish ph2 patients might be released 90 days after last patient's treatment. i think that might be allowed, but again will believe when i see! hope it's soon... we could all use a bit of TLT confidence building.
